Visual perception in prediagnostic and early stage Huntington's disease

Journal of the International Neuropsychological Society

Volumn 14, Issue 3, 2008, Pages 446-453

  O'Donnell, Brian F ^a   Blekhert, Tanya M ^b   Weaver, Marjorie ^b   White, Kerry M ^b   Marshall, Jeanine ^b   Beristain, Xabier ^b   Stout, Julie C ^a   Gray, Jacqueline ^b   Wojcieszek, Joanne M ^b   Foroud, Tatiana M ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast sensitivity; Huntington's disease; Neurodegenerative disease; Neuropsychology; Visual pathways; Visual perception

Indexed keywords

ADULT; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MAGNOCELLULAR NUCLEUS; MAJOR CLINICAL STUDY; MALE; MOVEMENT PERCEPTION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VISION TEST; VISUAL DISCRIMINATION; VISUAL DISORDER;

EID: 42449115680     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617708080405     Document Type: Article

References (43)

1. Barton, J.J., Simpson, T., Kiriakopoulos, E., Stewart, C., Crawley, A., Guthrie, B., Wood, M., & Mikulis, D. (1996). Functional MRI of lateral occipitotemporal cortex during pursuit and motion perception. Annals of Neurology, 40, 387-398.
2. Beglinger, L.J., Nopoulos, P.C., Jorge, R.E., Lanbehn, D.R., Mikos, A.E., Moser, D.J., Duff, K., Robinson, R.G., & Paulson, J.S. (2005). White matter volume and cognitive dysfunction in early Huntington's disease. Cognitive and Behavioral Neurology, 18, 102-107.
3. Blekher, T., Johnson, S.A., Marshall, J., White, K., Hui, S., Weaver, M., Gray, J., Yee, R., Stout, J.C., Beristain, X., Wojcieszek, J., & Foroud, T. (2006). Saccades in presymptomatic and early stages of Huntington disease. Neurology, 67, 394-399.
4. Bond, C. & Hodes, M.E. (1996). Direct amplification of the CAG Repeat of Huntington without amplification of CCG. Clinical Chemistry, 42, 773-774.
5. Brenner, C.A., Wilt, M.A., Lysaker, P.H., & O'Donnell, B.F. (2003). Psychometrically matched tasks of discrimination and recognition performance in schizophrenia spectrum disorders. Journal of Abnormal Psychology, 112, 28-37.
6. Egelhaaf, M., Borst, A., & Pilz, B. (1990). The role of GABA in detecting visual motion. Brain Research, 509, 156-160.
7. Ellenberger, J.C., Petro, D.J. & Ziegler, S.B. (1978). The visual evoked potentials in Huntington disease. Neurology, 28, 95-97.
8. Fennema-Notestine, C., Archibald, S.L., Jacobson, M.W., Corey-Bloom, C., Paulsen, J.S., Peavy, G.M., Gamst, A.C., Hamilton, J.M., Salmon, D.P., & Jernigan, T.L. (2004). In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology, 63, 989-995.
9. Festa, E.K., Insler, R.Z., Salmon, D.P., Paxton, J., Hamilton, J.M. & Heindel, W.C. (2005). Neocortical disconnectivity disrupts sensory integration in Alzheimer's disease. Neuropsychology, 19, 728-738.
10. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D.J., Hodes, M.E., Norton, J.A., Conneally, P.M., & Christian, J.C. (1995). Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Annals of Neurology, 37, 657-664.
11. Giersch, A. & Herzog, M.H. (2004). Lorazepam strongly prolongs visual information processing. Neuropsychopharmacology, 29, 1386-1394.
12. Gilmore, G.C., Cronin-Golomb, A., Neargarder, S.A., & Morrison, S.R. (2005). Enhanced stimulus contrast normalizes visual processing of rapidly presented letters in Alzheimer's disease. Vision Research, 45 1013-1020.
13. Gómez-Tortosa, E., del Barrio, A., Barroso, T., & Garcia Ruiz, P.J. (1996).Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. Journal of Neurology, 243, 286-292.
14. Hahn-Barma, V., Deweer, B., Dürr, A., Dodé, C., Feingold, J., Pillon, B., Agid, Y., Brice, A., & Dubois, B. (1998). Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. Journal of Neurology, Neurosurgery and Psychiatry, 64, 172-177.
15. Hinton, S.C., Paulsen, J.S., Hoffmann, R.G., Reynolds, N.C., Zimbelman, J.L., & Rao, S.M. (2007). Motor timing variability increases in preclinical Huntington's disease as estimate onset of motor symptoms approaches. Journal of the International Neuropsychological Society, 13, 539-543.
16. Ho, A.K., Sahakian, B.J., Brown, R.G., Barker, R.A., Hodges, J.R., Ané, M.N., Snowden, J., Thompson, J., Esmonde, T., Gentry, R., Moore, J.W., Bodner, T., & NEST - HD Consortium. (2003). Profile of cognitive progression in early Huntington's disease. Neurology, 61, 1702-1706.
17. Huntington Study Group. (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11, 136-142.
18. Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72 971-983.
19. Jacobs, D.H., Shuren, J., & Heilman, K.M. (1995). Impaired perception of facial identity and facial affect in Huntington's disease. Neurology, 45, 1217-1218.
20. Jason, G.W., Suchowersky, O., Pajurkova, E.M., Graham, L., Klimek. M.L.. Garber. A.T., & Poirier-Heine. D. (1497). Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Archives of Neurology, 54, 1081-1088.
21. Kirkwood, S.C., Siemers, E., Hodes, M.E., Conneally, P.M., Christian, J.C., & Foroud, T. (2000). Subtle changes among presymptomatic Huntington's disease mutation carriers. Journal of Neurology Neurosurgery and Psychiatry, 69, 773-779.
22. Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S., & Hayden, M.R. (2004). International Huntington's Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 65, 267-277.
23. Leventhal, A.G., Wang, Y., Pu, M., Zhou, Y., & Ma, Y. (2003). GABA and its agonists improvevisual cortical function in senescent monkeys. Science, 300, 812-815.
24. Levitt, H. (1971). Transformed up-down methods in psychoacoustics. Journal of the Acoustical Society of America 49, 467-477.
25. Livingstone, M. & Hubei, D. (1988). Segregation of form, color, movement and depth: Anatomy, physiology and perception. Science, 240, 740-749.
26. Mohr, E., Brouwers, P, Claus, J.J., Mann, U.M., Fedio, R, & Chase, T. (1991). Visuospatial cognition in Huntington's disease. Movement Disorders, 6, 127-132.
27. Mühlau, M., Weindl, A., Wohlschläger, A.M., Gaser, C., Städtler, M., Valet, M., Zimmer, C., Kassubek, J., & Peinemann, A. (2007). Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. Journal of Neural Transmission, 114, 367-372
28. O'Donnell, B.F., Bismark, A., Hetrick, W.P., Bodkins, M,, Vohs J.L. & Shekhar, A. (2006). Early stage vision in schizophrenia and schizotypal personality disorder. Schizophrenia Research, 86, 89-98.
29. O'Donnell, B.F., Wilt, M.A., Hake, A., Stout, J.C., Kirkwood, S.C., & Foroud, T. (2003). Visual function in Huntington's disease patients and presymptomatic mutation carriers. Movement Disorders, 18, 1027-1034.
30. Oepen, G., Doerr, M., & Thoden, U. (1981). Visual (VEP) and somatosensory (SSEP) evoked potentials is Huntington's chorea. Electroencephalography and Clinical Neurophysiology, 51, 666-670.
31. Rizzo, M., Anderson, S.W., Dawson, J., & Nawrot, M. (2002). Vision and cognition in Alzheimer's disease. Neuropsychologia, 38, 157-169.
32. Rodnitzky, R.L. (1998). Visual dysfunction in Parkinson's disease, Clinical Neuroscience, 5, 102-106.
33. Rosas, H.D., Liu, A.K., Hersch, S., Glessner, M., Ferrante, R.J., Salat, D.H., van der Kouwe, A., Jenkins, B.G., Dale, A.M., & Fischl, B. (2002). Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology, 58, 695-701.
34. Slaghuis, W.L. (1998). Contrast sensitivity for stationary and drifting spatial frequency gratings in positive- and negative-symptom schizophrenia. Journal of Abnormal Psychology, 107, 49-62.
35. Spear, P.D. (1993). Neural bases of visual deficits during aging. Vision Research, 33, 2589-2609.
36. Sprengelmeyer, R., Young, A.W., Calder, A.J., Karnat, A., Lange, H., Hömberg, V., Perrett, D.I., & Rowland, D. (1996). Loss of disgust: Perception of faces and emotions in Huntington's disease. Brain, 119 1647-1665.
37. Storey, E., Kowall, N.W., Finn, S.F., Mazurek, M.F., & Beal, M.F. (1992). The cortical legion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neuruchemical features by N-methyl-Daspartate lesions of rat cortex. Annals of Neurology, 32, 526-534.
38. Tyler, C.W. & McBride, B. (1995). The Morphonome Image Psychophysics Software and Calibrator for Macintosh Systems. Spatial Vision, 10, 479-484.
39. Uc, E.Y., Rizzo, M., Anderson, S.W., Qian, S., Rodnitzky, R.L., & Dawson, J.D. (2005). Visual dysfunction in Parkinson disease without dementia. Neurology, 65, 1907-1913.
40. Vaina, L.M., Cowey, A., Eskew, R.T. Jr, LeMay, M., & Kemper, T. (2001). Regional cerebral correlates of global motion perception: Evidence from unilateral cerebral brain damage. Brain, 124, 310-321.
41. Wandell, B A. (1995). Foundations of vision. Sunderland. MA: Sinauer.
42. Wandell,, B.A. (1999). Computational neuroimaging of human visual cortex. Annual Review of Neuroscience, 22, 145-173.
43. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corp.